biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
About
Team
Our offer
Knowledge base
News
Investor relations
Career
Contact
biuro@scopefluidics.com
+48 22 376 21 14
RAPORT ESPI 4/2017 | 28-09-2017 | Zawarcie znaczącej umowy – podpisanie umowy najmu lokalu
Previous Post
RAPORT EBI 8/2017 | 20-09-2017 | Powołanie Członków Rady Nadzorczej Scope Fluidics S.A.
Next Post
RAPORT ESPI 5/2017 | 02-10-2017 | Status projektu Bacteromic – zakończeniu pierwszego etapu
0
Shares
Related Posts
01.04.2025
Scope Fluidics Named “Stock Exchange Company of the Year 2024″ by Puls Biznesu
lk
0
08.01.2025
Scope Fluidics Reports Positive Results from Software Development for Rapid Detection
lk
0
08.01.2025
EAP Results Confirm Readiness for BACTEROMIC System Market Deployment
lk
0
